 | There's a slick YouTube video making the rounds arguing legal cannabis is being destroyed from the inside, and that Schedule III is the kill shot because it turns dispensaries into FDA-regulated pharmacies that only Big Pharma can afford. Half of it tracks: 280E was brutal, oversupply tanked wholesale, the illicit market still wins on price. But the punchline seems off to me. Everything I'm reading says the April order only touched state-licensed medical and FDA-approved products, recreational is still Schedule I, and rescheduling doesn't drag state-legal product into the FDA new-drug pathway unless a company chooses to build a prescription drug. The actual near-term effect looks like 280E relief, which helps operators, not pharma. Where I'm genuinely unsure: does Schedule III quietly "activate" dormant FDA authority in a way that bites independents down the road once interstate commerce opens? Or is the pharma-takeover thing just doom-bait? Operators who've sat through the legal briefings, what's your read? [link] [comments] |
Published: 2026-06-20T13:50:31+00:00
Link: https://www.reddit.com/r/weedbiz/comments/1uax53f/does_anyone_actually_buy_the_schedule_iii_hands/
